APA
McCarthy E. M., Sutton E., Nesbit S., Parker B., Jayne D., Griffiths B., Isenberg D. A., Rahman A., Gordon C., D'Cruz D. P., Rhodes B., Lanyon P., Vital E. M., Yee C., Edwards C. J., Teh L., Akil M., McHugh N. J., Zoma A. & Bruce I. N. (062017). The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. : Rheumatology (Oxford, England).
Chicago
McCarthy Eoghan M, Sutton Emily, Nesbit Stephanie, Parker Ben, Jayne David, Griffiths Bridget, Isenberg David A, Rahman Anisur, Gordon Caroline, D'Cruz David P, Rhodes Benjamin, Lanyon Peter, Vital Edward M, Yee Chee-Seng, Edwards Christopher J, Teh Lee-Suan, Akil Mohammed, McHugh Neil J, Zoma Asad and Bruce Ian N. 062017. The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. : Rheumatology (Oxford, England).
Harvard
McCarthy E. M., Sutton E., Nesbit S., Parker B., Jayne D., Griffiths B., Isenberg D. A., Rahman A., Gordon C., D'Cruz D. P., Rhodes B., Lanyon P., Vital E. M., Yee C., Edwards C. J., Teh L., Akil M., McHugh N. J., Zoma A. and Bruce I. N. (062017). The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. : Rheumatology (Oxford, England).
MLA
McCarthy Eoghan M, Sutton Emily, Nesbit Stephanie, Parker Ben, Jayne David, Griffiths Bridget, Isenberg David A, Rahman Anisur, Gordon Caroline, D'Cruz David P, Rhodes Benjamin, Lanyon Peter, Vital Edward M, Yee Chee-Seng, Edwards Christopher J, Teh Lee-Suan, Akil Mohammed, McHugh Neil J, Zoma Asad and Bruce Ian N. The potential overlapping populations for treatment with belimumab and rituximab using current NHS England and National Institute for Health and Care Excellence Guidelines in England and Wales. : Rheumatology (Oxford, England). 062017.